Skip to main content
. 2019 Mar 28;12(4):712–727. doi: 10.1016/j.stemcr.2019.02.012

Figure 6.

Figure 6

The Expression of BiP Is Increased in GBM and Predicts Sensitivity to SCD1 Inhibition

(A) TCGA analysis of BiP mRNA expression in normal non-tumor and GBM.

(B) Survival analysis in 525 GBM patients from the TCGA dataset based on high versus low BiP expression levels. p = 0.0005, log-rank test.

(C) Immunoblot analysis of SCD1 and BiP expression in NHA and eight GSC specimens.

See also Figure S7.